Tuesday, December 27, 2022

BioNTech doses first patient in herpes vaccine candidate clinical trial

https://ift.tt/JHqNCgv

Submitted December 28, 2022 at 09:22AM by aeranis https://ift.tt/8R4uNkl
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)